ISAPP announces an open registration mini-symposium on the human mycobiome.
Although the contribution of the intestinal microbiome in human physiology is well-studied, the specific role of intestinal fungi, the gut mycobiome, is not well understood. Yet they may play an important role in shaping host development and health. For example, the evidence that fungi are involved in development of chronic inflammatory diseases is building. Further, a healthy gut microbiome is likely a major line of defense against the detrimental spread of fungi from the intestinal environment to other parts of the body, or unwanted establishment of fungi in the gut itself. This mini-symposium features six short lectures that will explore different aspects of the human mycobiome, including research, clinical and industry perspectives.
Mini-symposium schedule, July 1, 2021
|10:00-10:05 AM EDT||Welcome. Eamonn Quigley/Mary Ellen Sanders||ISAPP|
|10:05-10:25||Overview of the human mycobiome. Pauline Scanlan||University College Cork, Ireland|
|Characterizing gut mycobiota from healthy adults: conventional vs vegetarian diets. Heather Hallen-Adams||University of Nebraska – Lincoln|
|10:45-11:05||Gut mycobiota in immunity and IBD. Iliyan D Iliev||Cornell University, Ithaca, NY|
|11:05-11:25||Mycobiome of infants in a type-1 diabetes prospective cohort. Joseph Petrosino||Baylor College of Medicine
|11:25-11:35||A clinician’s perspective on gut fungi. Eamonn Quigley||Houston Methodist,
Weill Cornell Medical College, TX
|11:35-11:40||Importance of the mycobiome: industry perspective. Frank Schuren||TNO, Microbiology & Systems Biology, The Netherlands|
The webinar was held on July 1, 2021 — see the recording here: